Viatris-Theramex Deal Under Scrutiny Amid Antitrust Concerns in the U.K.
Thursday, 4 April 2024, 12:55
Viatris-Theramex Women's Care Products Deal
The U.K.'s antitrust officials have expressed concerns over a deal that Viatris (VTRS) inked to sell rights for its women's care products to Theramex.
Antitrust Scrutiny in the U.K.
- The U.K.'s regulatory body is closely monitoring the implications of the deal.
- Theramex stands to benefit from acquiring the rights to Viatris' women's care products.
- However, potential antitrust issues could hinder the completion of the agreement.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.